RxDoctor Payments Data

Amr El-Naggar, MD

Neurological Surgery · Somerset, KYNPI 1033180757

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,020 of the $26,749 with a category attached, or 67.4%. Medtronic accounts for 81.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $12,973 and has fallen 97.1% since, to $380 in 2025.

$26,749in general payments, 2019–2025

Across 155 payments — averaging $172.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$22K
  • Integrity Implants Inc.$4K
  • Globus Medical$1K
  • Wenzel Spine, Inc.$130
  • Orthofix Medical, Inc.$87
  • Flowonix Medical Incorporated$43
  • plus $44 from 3 others
$23,334in research payments, 2019–2025

Across 9 payments — averaging $2592.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$23K

What the payments were for

  • Speaking & faculty fees$18,02067%
  • Travel & lodging$6,01722%
  • Food & beverage$2,69210%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,749 in reported general payments places this provider in the 80th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$251,932
Medicare patients
229
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen132$793
Cephalexin126$702
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52$441
Methylprednisolone60$275
Methocarbamol33$271
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$136
Diazepam75$133
Mupirocin29$120
Doxycycline Hyclate15$107
Gabapentin19$101
Ibuprofen13$37
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$33

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →